BioScrip, Inc. (NASDAQ:BIOS)
Industry: Healthcare

BioScrip, Inc. provides home infusion services in the United States. The company engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. BioScrip, Inc. offers its services at patient s homes, outpatient clinics, nursing facilities, physician s offices, and ambulatory infusion centers. The company markets and sells its products and services through sales and marketing representatives, payor relationships, and other government programs. BioScrip, Inc. was founded in 1993 and is based in Denver, Colorado.

Current Quote*
Last: $2.970
Change: 0.010
Book: $0.900
Volume: 940,651

As Of: 07/25 16:00 ET
*Quotes delayed by 20min.

Graphs for BIOS


3 Month Graph


6 Month Graph


1 Year Graph